Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells.

Leukemia & lymphoma - 1 Oct 2006

Haraguchi Kyoko, Takahashi Tsuyoshi, Nakahara Fumio, Matsumoto Akihiko, Kurokawa Mineo, Ogawa Seishi, Oda Hideaki, Hirai Hisamaru, Chiba Shigeru

Abstract excerpt

Invariant natural killer T (iNKT) cells are thought to regulate anti-tumor immunity. Human iNKT (i.e. Valpha24+ NKT) cells have been reported to recognize CD1d on target cells and show cytotoxicity directly on the target cells in vitro. However, the anti-tumor effect of mouse iNKT (i.e. Valpha14+ NKT) cells has been repeatedly reported to be dependent on the activity of natural killer (NK) cells via...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD1
Share to Antigens, CD1d

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cytokines

Share to Immunotherapy

Share to Killer Cells, Natural

Share to Ligands

Share to Neoplasm Transplantation

Share to T-Lymphocytes

Source

Identifiers

PMID: 17071498
DOI: 10.1080/10428190600682688

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD1d expression level in tumor cells is an important determinant for anti-tumor immunity by natural killer T cells.PMID 17071498Read ↗

Human CD1d knock-in mouse model demonstrates potent antitumor potential of human CD1d-restricted invariant natural killer T cellsSemantic proximity Read ↗

Tumor Cell Programmed Death Ligand 1-Mediated T Cell Suppression Is Overcome by Coexpression of CD80Semantic proximity Read ↗

Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humansSemantic proximity Read ↗

In vitro anti-tumour activity of alpha-galactosylceramide-stimulated human invariant Valpha24+NKT cells against melanoma.Semantic proximity Read ↗

A Subset of CD8αβ+ Invariant NKT Cells in a Humanized Mouse Model.Semantic proximity Read ↗

Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.Semantic proximity Read ↗

Targeted Expression of Human CD1d in Transgenic Mice Reveals Independent Roles for Thymocytes and Thymic APCs in Positive and Negative Selection of Vα14i NKT CellsSemantic proximity Read ↗

Dendritic cells combined with tumor cells and α-galactosylceramide induce a potent, therapeutic and NK-cell dependent antitumor immunity in B cell lymphoma.Semantic proximity Read ↗

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells.Semantic proximity Read ↗

CD20‐Specific Immunoligands Engaging NKG2D Enhance γδ T Cell‐Mediated Lysis of Lymphoma CellsSemantic proximity Read ↗

Blockade of PD‐L1 (B7‐H1) augments human tumor‐specific T cell responses <i>in vitro</i>Semantic proximity Read ↗

Activation of CD1d-restricted natural killer T cells can inhibit cancer cell proliferation during chemotherapy by promoting the immune responses in murine mesothelioma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.